Human germline genetic modification: scientific and bioethical perspectives

Kevin R. Smith, Sarah Chan, John Harris

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The latest mammalian genetic modification technology offers efficient and reliable targeting of genomic sequences, in the guise of designer genetic recombination tools. These and other improvements in genetic engineering technology suggest that human germline genetic modification (HGGM) will become a safe and effective prospect in the relatively near future. Several substantive ethical objections have been raised against HGGM including claims of unacceptably high levels of risk, damage to the status of future persons, and violations of justice and autonomy. This paper critically reviews the latest GM science and discusses the key ethical objections to HGGM. We conclude that major benefits are likely to accrue through the use of safe and effective HGGM and that it would thus be unethical to take a precautionary stance against HGGM.
Original languageEnglish
Pages (from-to)491-513
Number of pages23
JournalArchives of Medical Research
Volume43
Issue number7
DOIs
Publication statusPublished - Oct 2012

Fingerprint

genetic engineering
damages
autonomy
justice
human being
science

Cite this

@article{6c5c7e3d2be945189628cad7e8400630,
title = "Human germline genetic modification: scientific and bioethical perspectives",
abstract = "The latest mammalian genetic modification technology offers efficient and reliable targeting of genomic sequences, in the guise of designer genetic recombination tools. These and other improvements in genetic engineering technology suggest that human germline genetic modification (HGGM) will become a safe and effective prospect in the relatively near future. Several substantive ethical objections have been raised against HGGM including claims of unacceptably high levels of risk, damage to the status of future persons, and violations of justice and autonomy. This paper critically reviews the latest GM science and discusses the key ethical objections to HGGM. We conclude that major benefits are likely to accrue through the use of safe and effective HGGM and that it would thus be unethical to take a precautionary stance against HGGM.",
author = "Smith, {Kevin R.} and Sarah Chan and John Harris",
year = "2012",
month = "10",
doi = "10.1016/j.arcmed.2012.09.003",
language = "English",
volume = "43",
pages = "491--513",
journal = "Archives of Medical Research",
issn = "1873-5487",
number = "7",

}

Human germline genetic modification: scientific and bioethical perspectives. / Smith, Kevin R.; Chan, Sarah; Harris, John.

In: Archives of Medical Research, Vol. 43, No. 7, 10.2012, p. 491-513.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Human germline genetic modification: scientific and bioethical perspectives

AU - Smith, Kevin R.

AU - Chan, Sarah

AU - Harris, John

PY - 2012/10

Y1 - 2012/10

N2 - The latest mammalian genetic modification technology offers efficient and reliable targeting of genomic sequences, in the guise of designer genetic recombination tools. These and other improvements in genetic engineering technology suggest that human germline genetic modification (HGGM) will become a safe and effective prospect in the relatively near future. Several substantive ethical objections have been raised against HGGM including claims of unacceptably high levels of risk, damage to the status of future persons, and violations of justice and autonomy. This paper critically reviews the latest GM science and discusses the key ethical objections to HGGM. We conclude that major benefits are likely to accrue through the use of safe and effective HGGM and that it would thus be unethical to take a precautionary stance against HGGM.

AB - The latest mammalian genetic modification technology offers efficient and reliable targeting of genomic sequences, in the guise of designer genetic recombination tools. These and other improvements in genetic engineering technology suggest that human germline genetic modification (HGGM) will become a safe and effective prospect in the relatively near future. Several substantive ethical objections have been raised against HGGM including claims of unacceptably high levels of risk, damage to the status of future persons, and violations of justice and autonomy. This paper critically reviews the latest GM science and discusses the key ethical objections to HGGM. We conclude that major benefits are likely to accrue through the use of safe and effective HGGM and that it would thus be unethical to take a precautionary stance against HGGM.

U2 - 10.1016/j.arcmed.2012.09.003

DO - 10.1016/j.arcmed.2012.09.003

M3 - Article

VL - 43

SP - 491

EP - 513

JO - Archives of Medical Research

JF - Archives of Medical Research

SN - 1873-5487

IS - 7

ER -